About the Authors
- Adrienne Shnier
-
Affiliation Health Policy and Equity, School of Health Policy and Management, York University, Toronto, Canada
- Joel Lexchin
-
* E-mail: jlexchin@yorku.ca
Affiliations School of Health Policy and Management, York University, Toronto, Canada, University Health Network, Toronto, Canada, Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto, Canada
- Barbara Mintzes
-
Affiliation School of Population and Public Health, University of British Columbia, Vancouver, Canada
- Annemarie Jutel
-
Affiliation Graduate School of Nursing Midwifery and Health, Victoria University of Wellington, Wellington, New Zealand
- Kelly Holloway
-
Affiliation Department of Sociology, York University, Toronto, Canada
Competing Interests
In 2007 Joel Lexchin was a consultant to a law firm acting for Apotex Inc. In 2008 he was an expert witness for the Canadian federal government in its defence against a lawsuit challenging the ban on direct-to-consumer advertising. In 2010 he was an expert witness for a law firm representing the family of a plaintiff who allegedly died from an adverse reaction from a product made by Allergan. He is currently on the Management Board of Healthy Skepticism Inc. and is the Chair of the Health Action International - Europe Association Board. Barbara Mintzes is on the Health Action International - Europe Association Board. Joel Lexchin and Barbara Mintzes are Academic Editors at PLOS ONE. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials. The other authors report no conflicts of interest.
Author Contributions
Conceived and designed the experiments: JL. Performed the experiments: AS JL BM AJ KH. Analyzed the data: AS JL BM AJ KH. Wrote the paper: AS JL BM AJ KH.